Peer review reports
From: Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality
Original Submission |
27 Apr 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
16 Jun 2022 |
Reviewed |
Reviewer Report
|
13 Nov 2022 |
Reviewed |
Reviewer Report
|
30 Nov 2022 |
Author responded |
Author comments - Xingyu Zhang
|
Resubmission - Version 4 |
30 Nov 2022 |
Submitted |
Manuscript version 4
|
4 Dec 2022 |
Author responded |
Author comments - Xingyu Zhang
|
Resubmission - Version 5 |
4 Dec 2022 |
Submitted |
Manuscript version 5
|
Publishing |
12 Dec 2022 |
Editorially accepted |
|
27 Dec 2022 |
Article published |
10.1186/s12879-022-07940-z
|
Learn about peer review